Schering-Plough

Schering-Plough was a global biopharmaceutical company that focused on developing and manufacturing drugs, particularly in areas such as oncology, immunology, and respiratory diseases. Founded in 1851, it became known for products like allergy medications and treatments for various conditions. In 2009, Schering-Plough merged with Merck & Co., a larger pharmaceutical company, enhancing its research capabilities and product offerings. The merger aimed to create a stronger entity to tackle health challenges and innovate new therapies. The legacy of Schering-Plough continues through the products and developments stemming from this merger.